The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world observational study of fruquintinib in combination with irinotecan and capecitabine as second-line treatment in patients with advanced colorectal cancer.
 
Ling Xu
No Relationships to Disclose
 
Jinglei Qu
No Relationships to Disclose
 
Yu Cheng
No Relationships to Disclose
 
Ying Chen
No Relationships to Disclose
 
Jin Wang
No Relationships to Disclose
 
Xiujuan Qu
No Relationships to Disclose